Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.01.11.426218: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Production of Fab from IgG: Fab fragments were produced from purified IgGs of monoclonal antibodies 2-15, 2-43 and H4 by digestion with Papain in the presence of the reducing agent 30 mM cysteine and were purified by affinity chromatography on protein A following the manufacturer’s protocols (Thermo fisher). H4suggested: NoneBinding Affinity Measurements by Surface Plasmon Resonance: The binding affinities of antibodies to SARS-CoV-2 spike protein were determined using surface plasmon resonance (SPR) and a BIAcore T200 instrument (GE Healthcare) at 25°C. SARS-CoV-2 spike proteinsuggested: NoneThe … SciScore for 10.1101/2021.01.11.426218: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Production of Fab from IgG: Fab fragments were produced from purified IgGs of monoclonal antibodies 2-15, 2-43 and H4 by digestion with Papain in the presence of the reducing agent 30 mM cysteine and were purified by affinity chromatography on protein A following the manufacturer’s protocols (Thermo fisher). H4suggested: NoneBinding Affinity Measurements by Surface Plasmon Resonance: The binding affinities of antibodies to SARS-CoV-2 spike protein were determined using surface plasmon resonance (SPR) and a BIAcore T200 instrument (GE Healthcare) at 25°C. SARS-CoV-2 spike proteinsuggested: NoneThe anti-his antibody was first immobilized onto two different flow cells of a CM5 sensorchip (BR100030, Cyvita) surface using the His Capture Kit (28995056, Cyvita) according to the manufacturer’s protocol. anti-hissuggested: NoneDMEM supplemented with anti-VSV-G antibody (I1, mouse hybridoma supernatant from CRL-2700; ATCC) was added to the infected cells and they were cultured overnight as described above. anti-VSV-Gsuggested: NoneI1suggested: NoneCalculation of angle of approach: To measure the RBD approaching angle of antibodies, we first identify shared epitope residues among the five members of the VH1-2 antibody class. VH1-2suggested: NoneExperimental Models: Cell Lines Sentences Resources Expression vector was transiently transfected into Human Embryonic Kidney (HEK) 293 GnTI-Freestyle cells suspension culture in serum-free media (Invitrogen) using polyethyleneimine (Polysciences). HEKsuggested: NoneHEK293T cells were grown to 80% confluency before transfection with pCMV3-SARS-CoV-2-spike (kindly provided by Dr. Peihui Wang, Shandong University, China) using FuGENE 6 (Promega). HEK293Tsuggested: NoneIn brief, Vero E6 cells were seeded in a 96-well plate at a concentration of 2 × 104 cells per well. Vero E6suggested: NoneSoftware and Algorithms Sentences Resources The resulting data were fit to a 1:1 binding model using Biacore Evaluation Software and were plotted using Graphpad (Graphpad Prism 7.01, San Diego) Graphpadsuggested: (GraphPad, RRID:SCR_000306)The IC50 values were calculated using non-linear regression in GraphPad Prism. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)To identify somatic hypermutations, each antibody sequence was aligned to the assigned germline gene using MUSCLE v3.8.31 (Edgar, 2004) MUSCLEsuggested: (MUSCLE, RRID:SCR_011812)Data were collected on a Titan Krios electron microscope operating at 300 kV, equipped with a Gatan K3 direct electron detector and energy filter, using the Leginon software package. Leginonsuggested: (Leginon, RRID:SCR_016731)All processing was done using cryoSPARC v2.15.0 (Punjani et al., 2017). cryoSPARCsuggested: (cryoSPARC, RRID:SCR_016501)The model was then fitted interactively using ISOLDE 1.0.1 (Croll, 2018) and COOT 0.8.9.2 (Emsley and Cowtan, 2004) and using real space refinement in Phenix 1.18 (Adams et al., 2004). Phenixsuggested: (Phenix, RRID:SCR_014224)Validation was performed using Molprobity (Davis et al., 2004) and EMRinger (Barad et al., 2015). Molprobitysuggested: (MolProbity, RRID:SCR_014226)Diffraction data were processed with XDS (Kabsch, 2010) and scaled using AIMLESS (Evans, 2006) from the CCP4 software suite (Collaborative Computational Project, 1994) CCP4suggested: (CCP4, RRID:SCR_007255)Manual rebuilding of the structure using COOT (Emsley et al., 2010) was alternated with refinement using Phenix refine (Afonine et al., 2012) and PDB-REDO (Joosten et al., 2014). COOTsuggested: (Coot, RRID:SCR_014222)PISA was used to identify paratope-epitope interfaces and to calculate buried surface area (Krissinel and Henrick, 2007) PISAsuggested: (PISA, RRID:SCR_015749)PyMOL was used to determine the centre of mass of the shared epitope residues. PyMOLsuggested: (PyMOL, RRID:SCR_000305)Results from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-